SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7124EXEL 18 % on Q2 resultssjemmeri-8/4/2016
7123ADXS +23% on follow-through from yesterday's news.DewDiligence_on_SI-8/3/2016
7122ADXS +28% on AMGN collaboration: siliconinvestor.comDewDiligence_on_SI-8/2/2016
7121EVOK jumped yesterday and is up another 30+% this AM on huge volume. And this aIRWIN JAMES FRANKEL-7/28/2016
7120ALIM around 60% ATLANTA, July 26, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NAnigel bates-7/27/2016
7119I saw something on Cowen comments.Robohogs-7/23/2016
7118Oh well, let's just enjoy it. Hope not a buyout but something going on for fred hayes-7/22/2016
7117Best time for institutional funds to buy biotech stocks on a Friday in summer, wBiotech Jim-7/22/2016
7116It was pointed out to me that this data was presented Tuesday, though the confertuck-7/22/2016
7115The non abuse properties have been presented in the past. This preclinical stufffred hayes-7/22/2016
7114CARA has a long way to run. This will make many take notice. When does a bioBiotech Jim-7/22/2016
7113Re: CARA: presented preclinical data at a conference today wrt abuse potential, tuck-7/22/2016
7112CARA up over 25% now on 4x normal days vol. Nothing yet on why.IRWIN JAMES FRANKEL-7/22/2016
7111CARA > 20% on increasing volume. Don't see any news yet.sjemmeri-7/22/2016
7110ABLX on positive PIIb results for vobarilizumab (ALX-0061) in RA: hugin.info (nigel bates-7/7/2016
7109TTHI doubled [up 100%] in the premarket on buyout offer from OPK. An average dpgo-neil-6/30/2016
7108Tesaro's ovarian cancer drug shows benefit in late-stage trial finance.yahoJulius Wong-6/29/2016
7107ADXS +15% on Investor Day webcast.DewDiligence_on_SI-6/28/2016
7106MGNX had minor news of their own as to the closing of their May 18th announced dsjemmeri-6/28/2016
7105Looks like mgnx made the 15% hurdle in sympathy? Innate gets little credit for scaram(o)uche16/28/2016
7104XNCR up ~40 % on Xencor Announces Strategic Collaboration for Bispecific Programsjemmeri-6/28/2016
7103Cellectar Biosciences Announces Results of NCI-Sponsored Study of CLR 125 ShowinJulius Wong-6/23/2016
7102Eleven Biotherapeutics Announces Signing of Exclusive License Agreement financeJulius Wong-6/13/2016
7101Thanks Dew...fred hayes-6/10/2016
7100EGRX's partner, TEVA, won the Treanda patent case: siliconinvestor.com siliDewDiligence_on_SI-6/10/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News